Intermezzo^®

(zolpidem tartrate sublingual lozenge)
Phase 3 clinical trials have completed for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty returning to sleep.

Learn More

TO-2060

A novel fixed combination dose of olanzapine and ondansetron being evaluated for the treatment of dopamine associated psychiatric disorders.

Learn More